Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $34.31 USD
Change Today +0.19 / 0.56%
Volume 29.9K
MYGN On Other Exchanges
Symbol
Exchange
Frankfurt
As of 9:45 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark H. Skolnick Ph.D.

Former Chief Scientific Officer and Director, Myriad Genetics Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 4 different industries.

69--

Background*

Mr. Mark H. Skolnick Ph.D. was a Scientific Founder of Myriad Genetics Inc. and served as its Chief Scientific Officer since 1997. Dr. Skolnick served as Executive Vice President of Research and Development of Myriad Genetics Inc. from 1991 to July 2000. Dr. Skolnick directed the group that cloned the breast cancer susceptibility gene, BRCA1; found the full-length sequence of BRCA2; cloned the MMAC1 (PTEN) tumor suppressor gene; cloned a prostate cancer gene (HPC2); ...

Read Full Background

Corporate Headquarters*

320 Wakara Way
Salt Lake City, Utah 84108

United States

Phone: 801-584-3600
Fax: 801-584-3640

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
University of California Berkeley
Doctorate
Stanford University
PhD 1975
Stanford University
BA 1968
University of California

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MYGN:US $34.31 USD +0.19

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Frank S. Hermance Chairman, Chief Executive Officer and Chairman of Executive Committee
Ametek Inc.
$1.7M
Jen-Hsun Huang Co-Founder, Chief Executive Officer, President, Director and Member of Compensation Committee
NVIDIA Corporation
$998.4K
Carlo Bozotti Chairman of Management Board, Chief Executive Officer, President and Chairman of Corporate Strategic Committee
STMicroelectronics NV
$1.8M
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$1.0M
Hisashi Ietsugu Chairman of the Managing Board, Chief Executive Officer, President, Member of Global Strategic Committee, Member of Group Management Reporting Committee and Member of Steering Committee
Sysmex Corp.
¥250.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MYRIAD GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.